C3 and paroxysmal nocturnal hemoglobinuria: In any event, the most singular feature of C3 binding in PNH patients on eculizumab is that, despite all PNH RBCs are uniformly lacking GPI-anchored proteins, there are always two distinct PNH RBC populations with or without C3 binding.